-+ 0.00%
-+ 0.00%
-+ 0.00%

Humacyte Secures U.S. Patent Covering Symvess Manufacturing and Storage Into 2043

PUBT·10/28/2026 12:12:18
Humacyte Secures U.S. Patent Covering Symvess Manufacturing and Storage Into 2043
  • Humacyte received a U.S. patent covering Symvess and other bioengineered human tissues, extending protection for key platform technologies into 2043.
  • The patent covers key manufacturing and sterilization processes, including storage and shipping methods.
  • Symvess received FDA approval for extremity vascular trauma in December 2024; a supplemental application for dialysis access is planned this year.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Humacyte Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610280800PRIMZONEFULLFEED9854686) on October 28, 2026, and is solely responsible for the information contained therein.